Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Founder of Medivation LLC (California), Clarence Patrick Machado presently is Chairman at Armaron Bio Ltd. and Chairman at Adverum Biotechnologies, Inc.

He is also on the board of 10 other companies.

In the past Mr. Machado occupied the position of Principal at Morrison & Foerster LLP, Chief Financial Officer of Orion Acquisition Corp. II, Chief Financial Officer & Senior Vice President at Pro-Duct Health, Inc., Director at Medivation LLC (California), Chief Financial Officer, Director & Senior VP at Medivation Neurology LLC, Consultant at Cytyc Corp. and Chief Legal Counsel at Chiron Corp.

Clarence Patrick Machado received an undergraduate degree from Santa Clara University and a graduate degree from Harvard Law School.

Current positions of Clarence Patrick Machado 
NameTitle Since
Turning Point Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2019
Arcus Biosciences, Inc.
Independent Director 2019
Xenon Pharmaceuticals Inc.
(Biotechnology & Medical Research)
Independent Director 2020
Chimerix, Inc.
(Biotechnology & Medical Research)
Independent Director 2014
Montes Archimedes Acquisition Corp.
(Investment Holding Companies)
Independent Director -
Adverum Biotechnologies, Inc.
(Biotechnology & Medical Research)
Chairman 2019
Armaron Bio Ltd. Chairman 2015
Roivant Sciences Ltd. Independent Director 2017
Turnstone Biologics, Inc. Director -
Auransa, Inc. Director -
Roivant Sciences, Inc. Director -
Therachon Holding GmbH Member-Supervisory Board -
Turnstone Biologics Corp. Director -
ACELYRIN, Inc. Director 2021

Holdings of Clarence Patrick Machado 
Adverum Biotechnologies, Inc. (ADVM)
(Biotechnology & Medical Research)
88,1820.090%214,282 USD
Arcus Biosciences, Inc. (RCUS)
6,0000.0084%175,020 USD
Chimerix, Inc. (CMRX)
(Biotechnology & Medical Research)
10,0000.012%71,000 USD
Xenon Pharmaceuticals Inc. (XENE)
(Biotechnology & Medical Research)
00.0000%0 USD
Turning Point Therapeutics, Inc. (TPTX)
(Biotechnology & Medical Research)
00.0000%0 USD

Clarence Patrick Machado: Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
09:11aSTELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
More news

© 2021 People and Ownership :   
Clarence Patrick Machado : Connections